通过调节Th2,Th9和Treg分化,TXA2可以减轻过敏性肺炎
Hong Li1, J Alyce Bradbury1, Matthew L Edin1
1Division of Intramural Research, National Institute of Environmental Health Sciences/NIH, Research Triangle Park, North Carolina, USA.
The Journal of clinical investigation
|March 14, 2024
概括
惊人的是,血栓素A2 (TXA2) 抑制了Th9细胞分化,这是喘的一个关键驱动因素. 这种免疫抑制作用可能解释了为什么针对TXA2的喘疗法在人体试验中失败了.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
- T细胞的分化过程
背景情况:
- 血红素A2 (TXA2) 激活TP受体,导致肺部的炎症和支气管收缩.
- TP受体对抗剂和TXA2合成酶抑制剂正在作为喘治疗药物进行研究.
- Th9细胞在喘病原和调节肺部免疫反应方面至关重要.
研究的目的:
- 调查TXA2在过敏肺炎期间Th9细胞分化中的作用.
- 探索TXA2对Th9细胞介导喘进展的影响.
- 阐明抗血栓治疗在喘中的悖论性失败原因.
主要方法:
- 研究了TXA2对Th9细胞分化在体外使用原始CD4+T细胞的影响.
- 向过敏小鼠注射TXA2,并评估Th9细胞数量和气道过敏反应.
- 利用TP受体缺乏的小鼠在体内评估Th9细胞分化后的过敏原暴露.
主要成果:
- TXA2显著降低了Th9细胞的分化和IL-9的产生,以剂量依赖的方式.
- 在TXA2治疗过敏小鼠中,Th9细胞数量和气道过敏反应性下降.
- 缺乏TP受体的小鼠在暴露于过敏原后,肺部的Th9细胞数量增加.
- TXA2还抑制了Th2并增强了Treg分化,表明了更广泛的免疫抑制作用.
结论:
- TXA2对Th9细胞分化表现出免疫抑制作用,抵消其急性炎症作用.
- 这些发现表明,TXA2通过抑制Th9细胞来减轻喘进展的作用.
- TXA2的免疫抑制功能为抗血栓素喘治疗的临床失败提供了潜在的解释.
相关概念视频
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
02:06Allergic Reactions
27.4K
Overview
27.4K